Investing
Business Sale Proceeds
McKesson Business Sale Proceeds decreased by 90.5% to $4.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 95.6%, from $90.00M to $4.00M.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ4 2014
Last reportedQ1 2026Aug 6, 2025
How to read this metric
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
Detailed definition
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Peer comparison
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
Metric ID:
proceeds_from_sale_of_businessHistorical Data
12 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $83.00M | $413.00M | $578.00M | $240.00M | $1.03B | $39.00M | $54.00M | $90.00M | $43.00M | $4.00M | $42.00M | $4.00M |
| QoQ Change | — | +397.6% | +40.0% | -58.5% | +329.2% | -96.2% | +38.5% | +66.7% | -52.2% | -90.7% | +950.0% | -90.5% |
| YoY Change | — | — | — | +189.2% | — | -83.8% | — | +130.8% | -20.4% | — | — | -95.6% |
Range$4.00M – $1.03B
CAGR-66.8%
Avg YoY Growth+24.0%
Median YoY Growth-20.4%
Business Sale Proceeds at Other Companies
Frequently Asked Questions
- What is McKesson's business sale proceeds?
- McKesson (MCK) reported business sale proceeds of $4.00M in Q2 2025.
- How has McKesson's business sale proceeds changed year-over-year?
- McKesson's business sale proceeds decreased by 95.6% year-over-year, from $90.00M to $4.00M.
- What does business sale proceeds mean?
- Cash received from selling off parts of the business.